Pharmacological inhibition of palmitoyltransferase DHHC3 by 2-bromopalmitate (2-BP) promotes PD-L1 autophagic degradation and enhances antitumor activity in a colon tumor model29. Here, ZDHHC3 is linked to colonic neoplasm.